驴抗小鼠IgG H&L (HRP)预吸附二抗(ab98799)
Key features and details
- Donkey Anti-Mouse IgG H&L (HRP) preadsorbed
- Conjugation: HRP
- Host species: Donkey
- Isotype: IgG
- Suitable for: IHC-P, ELISA, WB, ICC
概述
-
产品名称
驴抗小鼠IgG H&L (HRP)预吸附二抗
参阅全部 IgG 二抗 -
宿主
Donkey -
靶标种属
Mouse -
经测试应用
适用于: IHC-P, ELISA, WB, ICCmore details -
最小交叉反应
Chicken, Cow, Goat, Horse, Human, Rabbit, Rat, Sheep more details -
偶联物
HRP
性能
-
形式
Liquid -
存放说明
Shipped at 4°C. Store at +4°C. -
存储溶液
pH: 6.8
Constituents: 0.2% BSA, 0.05% CMIT/MIT based preservative -
Concentration information loading...
-
纯度
Immunogen affinity purified -
纯化说明
This antibody was isolated by affinity chromatography using antigen coupled to agarose beads and conjugated to Horse Radish Peroxidase. -
克隆
多克隆 -
同种型
IgG -
研究领域
相关产品
-
Substrate reagent
- TMB ELISA Substrate (Highest Sensitivity) (ab171522)
- TMB ELISA Substrate (High Sensitivity) (ab171523)
- TMB ELISA Substrate (Fast Kinetic Rate) (ab171524)
- TMB ELISA Substrate (Slow Kinetic Rate) (ab171525)
- TMB ELISA Substrate (Slower Kinetic Rate) (ab171526)
- TMB ELISA Substrate (Slowest Kinetic Rate) (ab171527)
应用
The Abpromise guarantee
Abpromise™承诺保证使用ab98799于以下的经测试应用
“应用说明”部分 下显示的仅为推荐的起始稀释度;实际最佳的稀释度/浓度应由使用者检定。
应用 | Ab评论 | 说明 |
---|---|---|
IHC-P |
1/200 - 1/5000.
|
|
ELISA |
1/10000 - 1/100000. Primary dilution.
|
|
WB |
1/5000 - 1/50000. Colorimetric: Use 1/5,000-1/30,000 dilution; Chemiluminescent: Use 1/10,000-1/50,000 dilution.
|
|
ICC |
Use at an assay dependent dilution.
|
说明 |
---|
IHC-P
1/200 - 1/5000. |
ELISA
1/10000 - 1/100000. Primary dilution. |
WB
1/5000 - 1/50000. Colorimetric: Use 1/5,000-1/30,000 dilution; Chemiluminescent: Use 1/10,000-1/50,000 dilution. |
ICC
Use at an assay dependent dilution. |
实验方案
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
数据表及文件
-
SDS download
-
Datasheet download
文献 (8)
ab98799 被引用在 8 文献中.
- Fukushi M et al. Optineurin deficiency impairs autophagy to cause interferon beta overproduction and increased survival of mice following viral infection. PLoS One 18:e0287545 (2023). PubMed: 37352136
- Hinden L et al. Opposite physiological and pathological mTORC1-mediated roles of the CB1 receptor in regulating renal tubular function. Nat Commun 13:1783 (2022). PubMed: 35379807
- Pandey SK et al. Silencing VDAC1 to Treat Mesothelioma Cancer: Tumor Reprograming and Altering Tumor Hallmarks. Biomolecules 12:N/A (2022). PubMed: 35883451
- Baraghithy S et al. Renal Proximal Tubule Cell Cannabinoid-1 Receptor Regulates Bone Remodeling and Mass via a Kidney-to-Bone Axis. Cells 10:N/A (2021). PubMed: 33671138
- Pittala S et al. The VDAC1-based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes Mellitus. Cells 9:N/A (2020). PubMed: 32093016
- Azar S et al. Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARa dependent. Mol Metab 42:101087 (2020). PubMed: 32987186
- Drori A et al. CB1R regulates soluble leptin receptor levels via CHOP, contributing to hepatic leptin resistance. Elife 9:N/A (2020). PubMed: 33210603
- Yannai S et al. Combinatorial treatment increases IKAP levels in human cells generated from Familial Dysautonomia patients. PLoS One 14:e0211602 (2019). PubMed: 30889183